| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $42.2M | +67.9% |
| SG&A Expense | $18.1M | +79.0% |
| Operating Income | -$60.3M | -71.0% |
| Income Tax | $0 | — |
| Net Income | -$58.8M | -66.7% |
| EPS (Basic) | -$1.96 | +78.1% |
| EPS (Diluted) | -$1.96 | +78.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $121.6M | -18.4% |
| Current Assets | $196.7M | +28.0% |
| Total Assets | $223.9M | +39.9% |
| Current Liabilities | $10.5M | +43.8% |
| Total Liabilities | $28.4M | +267.5% |
| Stockholders' Equity | $195.6M | +28.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$54.6M | -68.5% |
| Capital Expenditures | $1.1M | -48.5% |
| Investing Cash Flow | -$67.9M | -3093.8% |
| Financing Cash Flow | $95.6M | -42.5% |
| Free Cash Flow | -$55.7M | -61.3% |